® OptiBiotix is launching into the US after receiving FDA registration for its improved version microbiome modulating weight loss product, Slimbiome® and its cholesterol-reduction product, LP-LDL. The launch which is being held at the Supply Side West event, (Las Vegas between 25th-29th September) where OptiBiotix will be exhibiting alongside its potential US joint development partner, Cereal Ingredients Inc.
Cereal Ingredients, a privately-held specialty ingredients manufacturer, is looking to incorporate Slimbiome® into its range of cereal-based particulates and ingredients, which are aimed at the nutraceutical, health, and wellbeing sectors.
Slimbiome® is a unique combination of clinically proven ingredients backed by thousands of humns studies, formulated by experts to support healthy weight management and weight loss. It promotes the feeling of fullness, helps burn calories by promoting a healthy metabolism, maintains blood sugar levels to reduce food cravings and overeating, and improves microbiome diversity. Slimbiome® has the potential to be used as an ingredient in dietary supplements, and in other over the counter (OTC) weight loss applications.
The improved version of Slimbiome® being launched at Supply Side West has been developed by Optibiotix using advanced processing technology. The new formulation is a single, homogenous product, making it less likely that components will separate in transit, as well as improving the overall consistency of the product. The product has also been made more soluble to enhance its flavour and improve mouthfeel.
Optibiotix’s CEO, Stephen O’Hara, commented, “Our launch into the US is a very exciting step for Optibiotix. We are particularly pleased to be exhibiting at Supply Side West alongside our potential US partner, Cereal Ingredients. We are delighted with consumer feedback with customers using GoFigure products containing SlimBiome reporting reduced hunger, less snacking and easier weight loss of on average 2-3lbs per week.Hunger free dieting is now a consumer option and we hope our meetings at Supply Side West will lead to a wider range of products containing this unique formulation to support consumer choice.”
The human microbiome
The human digestive tract contains a complex and diverse ecosystem of trillions of bacteria. Recently, advances in molecular and analytical techniques (metagenomics, metabolomics) have permitted identification and quantitation of species and strains of bacteria that inhabit the gastrointestinal tract, their metabolic activity, and interactions with the human host. These studies have provided greater insight into the role of gut and their metabolites in health and disease. NIH https://commonfund.nih.gov/hmp/index
Web MD http://www.webmd.com/digestive-disorders/what-your-gut-bacteria-say-your-health#1
About OptiBiotix
OptiBiotix was formed in March 2012 to develop compounds which modify the human microbiome – the collective genome of the microbes in the body – to prevent and manage human disease. The aim of OptiBiotix is to discover and develop microbial strains, compounds and formulations, which modulate the human microbiome and can be used as food ingredients and supplements or active compounds for the prevention and management of human metabolic diseases, examples of which include obesity, cholesterol and lipid distribution and diabetes. OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is fuelled by its proprietary OptiScreen® and OptiBiotic® platform technologies designed to identify metabolic pathways and compounds that impact on human physiology and bring potential health benefits. These platforms are applicable across a wider range of other human diseases.
About The Healthy Weight Loss Company
The Healthy Weight Loss Company (THWLC) is jointly owned by OptiBiotix Health plc (64%), Anna Maia, and Max Tomlinson. The Company was formed in July 2016 as a platform for OptiBiotix to incubate new technological solutions and develop wider product applications in weight management.
THWLC sells GoFigure® snacks and shakes containing OptiBiotix’s proprietary Slimbiome® technology under a non-exclusive UK license agreement. The use of SlimBiome® in the GoFigure® range establishes use of the technology in food products and supports the wider use of Slimbiome® technology in dietary supplements and over the counter (OTC) applications, both in the UK and internationally.
